Audacious CRISPR interference petition complicates ongoing Cas9 dispute
Sigma-Aldrich seeks to revive its claims to patents reading on the gene technology by inserting itself into the dispute between the Broad and the University of California.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.